Literature DB >> 1964579

Effects of a new 1,3-thiazole derivative ZSY-39 on force of contraction and cyclic AMP content in canine ventricular muscle.

M Endoh1, H Satoh, I Norota, K Hirano.   

Abstract

A newly synthesized 1,3-thiazole derivative ZSY-39 increased the force of contraction in a concentration-dependent manner in association with elevation of tissue cyclic AMP levels in the isolated canine ventricular trabeculae electrically driven at 0.5 Hz at 37 degrees C. ZSY-39 shortened the duration of isometric contractions mainly by abbreviation of the relaxation time. The maximal response to and EC50 of ZSY-39 were 0.7 (isoproterenol = 1.0) and 4.6 x 10(-5) M. Bupranolol (3 x 10(-7) M) did not affect the positive inotropic effect of ZSY-39. The time course of increases in the force of contraction induced by ZSY-39 (10(-4) M) coincided with that of cyclic AMP accumulation. The concentration-response curve for the increase in the force of contraction produced by ZSY-39 was superimposable on that of the elevation of cyclic AMP levels. Carbachol (3 x 10(-6) M) shifted the concentration-response curve for the increase in force by ZSY-39 to the right and downward, and decreased the accumulation of cyclic AMP induced by ZSY-39 (10(-4) M). ZSY-39 (10(-5) M) enhanced significantly the positive inotropic effect of isoproterenol. The relationship between the force of contraction and cyclic AMP levels after the administration of ZSY-39 was not modified by the addition of carbachol or isoproterenol. These findings indicate that cyclic AMP plays an important role in the positive inotropic effect of ZSY-39 on canine ventricular muscle.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964579     DOI: 10.1007/bf01856509

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  37 in total

1.  Effects of several phosphodiesterase-inhibitors on guinea-pig myocardium.

Authors:  M Korth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-03       Impact factor: 3.000

Review 2.  Cyclic AMP and contractile activity in heart.

Authors:  R W Tsien
Journal:  Adv Cyclic Nucleotide Res       Date:  1977

3.  The regulation of the calcium sensitivity of the contractile system in mammalian cardiac muscle.

Authors:  G B McClellan; S Winegrad
Journal:  J Gen Physiol       Date:  1978-12       Impact factor: 4.086

4.  Biphasic contractions induced by milrinone at low temperature in ferret ventricular muscle: role of the sarcoplasmic reticulum and transmembrane calcium influx.

Authors:  C O Malecot; D M Bers; B G Katzung
Journal:  Circ Res       Date:  1986-08       Impact factor: 17.367

5.  Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance.

Authors:  M H Crawford; K L Richards; M T Sodums; G T Kennedy
Journal:  Am J Cardiol       Date:  1984-04-01       Impact factor: 2.778

6.  The time course of changes in cyclic nucleotide levels during cholinergic inhibition of positive inotropic actions of isoprenaline and theophylline in the isolated canine ventricular myocardium.

Authors:  M Endoh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

7.  Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.

Authors:  M Endoh; S Yamashita; N Taira
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

8.  Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.

Authors:  D S Baim; A V McDowell; J Cherniles; E S Monrad; J A Parker; J Edelson; E Braunwald; W Grossman
Journal:  N Engl J Med       Date:  1983-09-29       Impact factor: 91.245

9.  A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.

Authors:  R DiBianco; R Shabetai; W Kostuk; J Moran; R C Schlant; R Wright
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

10.  Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure.

Authors:  S Sasayama; M Inoue; H Asanoi; K Kodama; M Hori; T Sakurai; C Kawai
Journal:  Heart Vessels       Date:  1986       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.